News · Approval
1,552 stories
May 15, 26Durvalumab Plus BCG Reduces High-Risk NMIBC Recurrence or Death Risk by 32% in Phase 3 POTOMAC Trial
May 15, 26Opinion: Telehealth abortion with mifepristone continues, with backup plans still in place
May 14, 26STAT+: The hunt for FDA’s next leader
May 14, 26STAT+: Three years of declining overdose deaths begets cautious optimism and some concerns